1. Home
  2. ACMR vs MESO Comparison

ACMR vs MESO Comparison

Compare ACMR & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACMR
  • MESO
  • Stock Information
  • Founded
  • ACMR 1998
  • MESO 2004
  • Country
  • ACMR United States
  • MESO Australia
  • Employees
  • ACMR N/A
  • MESO N/A
  • Industry
  • ACMR Industrial Machinery/Components
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ACMR Technology
  • MESO Health Care
  • Exchange
  • ACMR Nasdaq
  • MESO Nasdaq
  • Market Cap
  • ACMR 1.3B
  • MESO 1.3B
  • IPO Year
  • ACMR 2017
  • MESO N/A
  • Fundamental
  • Price
  • ACMR $31.68
  • MESO $15.94
  • Analyst Decision
  • ACMR Buy
  • MESO Buy
  • Analyst Count
  • ACMR 5
  • MESO 4
  • Target Price
  • ACMR $30.50
  • MESO $18.00
  • AVG Volume (30 Days)
  • ACMR 862.3K
  • MESO 332.3K
  • Earning Date
  • ACMR 08-06-2025
  • MESO 08-28-2025
  • Dividend Yield
  • ACMR N/A
  • MESO N/A
  • EPS Growth
  • ACMR 19.75
  • MESO N/A
  • EPS
  • ACMR 1.57
  • MESO N/A
  • Revenue
  • ACMR $802,274,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • ACMR $19.19
  • MESO $178.09
  • Revenue Next Year
  • ACMR $15.21
  • MESO $305.06
  • P/E Ratio
  • ACMR $20.16
  • MESO N/A
  • Revenue Growth
  • ACMR 26.21
  • MESO N/A
  • 52 Week Low
  • ACMR $13.87
  • MESO $5.78
  • 52 Week High
  • ACMR $32.45
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • ACMR 70.98
  • MESO 67.42
  • Support Level
  • ACMR $29.12
  • MESO $14.45
  • Resistance Level
  • ACMR $30.54
  • MESO $17.63
  • Average True Range (ATR)
  • ACMR 1.05
  • MESO 0.54
  • MACD
  • ACMR 0.06
  • MESO 0.43
  • Stochastic Oscillator
  • ACMR 82.45
  • MESO 75.51

About ACMR ACM Research Inc.

ACM Research Inc supplies advanced, innovative capital equipment developed for the global semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: